Clinical Trial Update: Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Zevalin/BEAM/Rituximab versus BEAM/Rituximab with or without Rituximab as conditioning for autologous stem cell transplantation in diffu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Lymphoma

Drugs mentioned

• BEAM
• Rituxan (rituximab) (rituximab)
• Rituximab (unspecified formulation) (rituximab)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Diffuse Large Cell Lymphoma, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02